Mpex Pharmaceuticals, Inc.

17 articles about Mpex Pharmaceuticals, Inc.

• Synteract, Inc. (San Diego) and Mpex Pharmaceuticals, Inc. Team Up for Cystic Fibrosis Walk and Cure

  5/18/2011

• Axcan Pharma to Buy Mpex Pharmaceuticals, Inc. for Phase III-Stage Aerosol Antibiotic; Mpex Plans to Spin Out the Aeroquin Assets into a New Company

  4/14/2011

• Mpex Pharmaceuticals, Inc. Initiates Phase 3 Clinical Trial Program with Aeroquin(TM) for the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

  1/10/2011

• Mpex Pharmaceuticals, Inc. Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients

  5/17/2010

• Mpex Pharmaceuticals, Inc. Reports Positive Phase II Results with Aeroquin, Delivered by PARI Pharma's eFlow Technology

  9/15/2009

• Mpex Pharmaceuticals, Inc. Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) Treatment in Cystic Fibrosis Patients; Primary Endpoint Met

  9/10/2009

• Mpex Pharmaceuticals, Inc. Names Mark Wiggins Chief Business Officer

  4/20/2009

• Mpex Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD

  11/3/2008

• Mpex Pharmaceuticals, Inc. Presents New Data on MP-376 in Cystic Fibrosis

  10/23/2008

• Mpex Pharmaceuticals, Inc. Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

  6/25/2008

• GlaxoSmithKline Signs Superbug Drug Alliance with Mpex Pharmaceuticals, Inc.

  6/16/2008

• Mpex Pharmaceuticals, Inc. Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis

  3/4/2008

• Mpex Pharmaceuticals, Inc. Names Dr. Jeffery Loutit as Chief Medical Officer

  9/17/2007

• Mpex Pharmaceuticals, Inc. Initiates Multi-Dose Clinical Trial in the U.S. with MP-376 in Patients with Cystic Fibrosis

  7/18/2007

• Mpex Pharmaceuticals, Inc. Names Daniel D. Burgess as Chief Executive Officer

  5/22/2007

• Mpex Pharmaceuticals, Inc. Appoints Matthew A. Wikler To The Position Of Chief Medical Officer

  1/6/2006

• Mpex Pharmaceuticals, Inc. Names Mike Dudley To New Position Of Vice President Of Drug Development

  11/10/2005